Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...
The Chosun Ilbo on MSN
Merck Invests 4 Trillion Won in AI Drug Development Platform
German pharmaceutical company Merck (Merck) signed a contract worth 4 trillion Korean won on the 20th to adopt the AI-based new drug development platform of U.S. bio company BaloHealth. A source from ...
VANCOUVER, BC / ACCESS Newswire / November 25, 2025 /Variational AI, a leading innovator in generative artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback